Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023. These Common Shares will be under lockup for 89 days starting from 27-JUN-2023 to.
The trial for the drug to treat acute stroke sufferers has hit a snag due to surging import costs, with the price of a vial going from ¥300,000 to ¥1.6 million.